The other side of MMPs: Protective roles in tumor progression

Cancer and Metastasis Reviews

Volumn 26, Issue 3-4, 2007, Pages 717-724

  Martin, Michelle D ^a   Matrisian, Lynn M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Metastasis; MMPs; Tumor progression

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN;

CANCER INVASION; CARCINOGENESIS; DRUG TARGETING; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; TUMOR GROWTH; TUMOR VASCULARIZATION;

DISEASE PROGRESSION; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 36148994693     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-007-9089-4     Document Type: Review

References (58)

1. Fingleton, B. (2006). Matrix metalloproteinases: Roles in cancer and metastasis. Frontiers in Bioscience, 11, 479-491.
2. Egeblad, M., & Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer, 2, 161-174.
3. Gross, J., & Lapiere, C. M. (1962). Collagenolytic activity in amphibian tissues: A tissue culture assay. Proceedings of the National Academy of Sciences of the United States of America, 48, 1014-1022.
4. Benaud, C., Dickson, R. B., & Thompson, E. W. (1998). Roles of the matrix metalloproteinases in mammary gland development and cancer. Breast Cancer Research and Treatment, 50, 97-116.
5. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., & Shafie, S. (1980). Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature, 284, 67-68.
6. Brinckerhoff, C. E., & Matrisian, L. M. (2002). Matrix metalloproteinases: A tail of a frog that became a prince. Nature Reviews. Molecular Cell Biology, 3, 207-214.
7. McCawley, L. J., & Matrisian, L. M. (2001). Matrix metalloproteinases: They're not just for matrix anymore! Current Opinion in Cell Biology, 13, 534-540.
8. Martin, M. D., & Matrisian, L. M. (2005). Matrix metalloproteinases as prognostic factors for cancer. Clinical Laboratory Investigations, 28, 16-18.
9. Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., et al. (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature, 348, 699-704.
10. Heppner, K. J., Matrisian, L. M., Jensen, R. A., & Rodgers, W. H. (1996). Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. American Journal of Pathology, 149, 273-282.
11. Lynch, C. C., & Matrisian, L. M. (2002). Matrix metalloproteinases in tumor-host cell communication. Differentiation, 70, 561-573.
12. Deryugina, E. I., & Quigley, J. P. (2006). Matrix metalloproteinases and tumor metastasis. Cancer and Metastasis Reviews, 25, 9-34.
13. Koop, S., Khokha, R., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Chambers, A. F., et al. (1994). Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Research, 54, 4791-4797.
14. Whitelock, J. M., Murdoch, A. D., Iozzo, R. V., & Underwood, P. A. (1996). The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. Journal of Biological Chemistry, 271, 10079-10086.
15. Imai, K., Hiramatsu, A., Fukushima, D., Pierschbacher, M. D., & Okada, Y. (1997). Degradation of decorin by matrix metalloproteinases: Identification of the cleavage sites, kinetic analyses and transforming growth factor-beta 1 release. Biochemical Journal, 322, 809-814.
16. Manes, S., Mira, E., Barbacid, M. M., Cipres, A., Fernandez-Resa, P., Buesa, J. M., et al. (1997). Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. Journal of Biological Chemistry, 272, 25706-25712.
17. Manes, S., Llorente, M., Lacalle, R. A., Gomez-Mouton, C., Kremer, L., Mira, E., et al. (1999). The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells. Journal of Biological Chemistry, 274, 6935-6945.
18. Agrez, M., Chen, A., Cone, R. J., Pytela, R., & Sheppard, D. (1994). The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain. Journal of Cell Biology, 127, 547-556.
19. Powell, W. C., Fingleton, B., Wilson, C. L., Boothby, M., & Matrisian, L. M. (1999). The metalloproteinase matrilysin (MMP-7) proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Current Biology, 9, 1441-1447.
20. Fingleton, B., Vargo-Gogola, T., Crawford, H. C., & Matrisian, L. M. (2001). Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia, 3, 459-468.
21. Vargo-Gogola, T., Crawford, H. C., Fingleton, B., & Matrisian, L. M. (2002). Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Archives of Biochemistry and Biophysics, 408, 155-161.
22. Balbin, M., Fueyo, A., Tester, A. M., Pendas, A. M., Pitiot, A. S., Astudillo, A., et al. (2003). Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nature Genetics, 35, 252-257.
23. D'Armiento, J., DiColandrea, T., Dalal, S. S., Okada, Y., Huang, M. T., Conney, A. H., et al. (1995). Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Molecular and Cellular Biology, 15, 5732-5739.
24. McCawley, L. J., Crawford, H. C., King, L. E., Jr., Mudgett, J., & Matrisian, L. M. (2004). A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Research, 64, 6965-6972.
25. Witty, J. P., Lempka, T., Coffey, R. J., Jr., & Matrisian, L. M. (1995). Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Research, 55, 1401-1406.
26. Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J. P., Gray, J. W., et al. (1999). The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell, 98, 137-146.
27. Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., et al. (2005). Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 436, 123-127.
28. Kerkela, E., Ala-aho, R., Klemi, P., Grenman, S., Shapiro, S. D., Kahari, V. M., et al. (2002). Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. Journal of Pathology, 198, 258-269.
29. Schultz, R. M., Silberman, S., Persky, B., Bajkowski, A. S., & Carmichael, D. F. (1988). Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Research, 48, 5539-5545.
30. Khokha, R. (1994). Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. Journal of the National Cancer Institute, 86, 299-304.
31. Watanabe, M., Takahashi, Y., Ohta, T., Mai, M., Sasaki, T., Seiki, M., et al. (1996). Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice. Cancer, 77, 1676-1680.
32. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Research, 58, 1048-1051.
33. Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R., et al. (1999). Experimental metastasis is suppressed in MMP-9-deficient mice. Clinical & Experimental Metastasis, 17, 177-181.
34. Agarwal, D., Goodison, S., Nicholson, B., Tarin, D., & Urquidi, V. (2003). Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model. Differentiation, 71, 114-125.
35. Montel, V., Kleeman, J., Agarwal, D., Spinella, D., Kawai, K., & Tarin, D. (2004). Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Research, 64, 1687-1694.
36. Hotary, K. B., Allen, E. D., Brooks, P. C., Datta, N. S., Long, M. W., & Weiss, S. J. (2003). Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell, 114, 33-45.
37. Sabeh, F., Ota, I., Holmbeck, K., Birkedal-Hansen, H., Soloway, P., Balbin, M., et al. (2004). Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP 2. Journal of Cell Biology, 167, 769-781.
38. Zhai, Y., Hotary, K. B., Nan, B., Bosch, F. X., Munoz, N., Weiss, S. J., et al. (2005). Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Research, 65, 6543-6550.
39. Tsunezuka, Y., Kinoh, H., Takino, T., Wantanabe, Y., Okada, Y., Shainagawa, A., et al. (1996). Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay. Cancer Research, 56, 5678-5683.
40. Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell, 103, 481-490.
41. Acuff, H. B., Carter, K. J., Fingleton, B., Gorden, D. L., & Matrisian, L. M. (2006). Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment 1. Cancer Research, 66, 259-266.
42. Chantrain, C. F., Shimada, H., Jodele, S., Groshen, S., Ye, W., Shalinsky, D. R., et al. (2004). Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Research, 64, 1675-1686.
43. Jodele, S., Blavier, L., Yoon, J. M., & DeClerck, Y. A. (2006). Modifying the soil to affect the seed: Role of stromal-derived matrix metalloproteinases in cancer progression. Cancer and Metastasis Reviews, 25, 35-43.
44. Folkman, J. (2004). Endogenous angiogenesis inhibitors. Apmis, 112, 496-507.
45. Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J. C., Maeshima, Y., Yang, C., et al. (2003). Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaVbeta3 integrin. Cancer Cell, 3, 589-601.
46. Pozzi, A., Moberg, P. E., Miles, L. A., Wagner, S., Soloway, P., & Gardner, H. A. (2000). Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proceedings of the National Academy of Sciences of the United States of America, 97, 2202-2207.
47. Chen, X., Su, Y., Fingleton, B., Acuff, H., Matrisian, L. M., Zent, R., et al. (2005). Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells. International Journal of Cancer, 116, 52-61.
48. Chen, X., Su, Y., Fingleton, B., Acuff, H., Matrisian, L. M., Zent, R., et al. (2005). An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice. Clinical & Experimental Metastasis, 22, 185-193.
49. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., et al. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biology, 2, 737-744.
50. Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., et al. (2002). MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell, 2, 289-300.
51. Nabha, S. M., Bonfil, R. D., Yamamoto, H. A., Belizi, A., Wiesner, C., Dong, Z., et al. (2006). Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis. Clinical & Experimental Metastasis, 23, 335-344.
52. Dong, Z., Kumar, R., Yang, X., & Fidler, I. J. (1997). Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell, 88, 801-810.
53. Houghton, A. M., Grisolano, J. L., Baumann, M. L., Kobayashi, D. K., Hautamaki, R. D., Nehring, L. C., et al. (2006). Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. Cancer Research, 66, 6149-6155.
54. Acuff, H. B., Sinnamon, M., Fingleton, B., Boone, B., Levy, S. E., Chen, X., et al. (2006). Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. Cancer Research, 66, 7968-7975.
55. Hofmann, H. S., Hansen, G., Richter, G., Taege, C., Simm, A., Silber, R. E., et al. (2005). Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clinical Cancer Research, 11, 1086-1092.
56. Shipley, J. M., Wesselschmidt, R. L., Kobayashi, D. K., Ley, T. J., & Shapiro, S. D. (1996). Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proceedings of the National Academy of Sciences of the United States of America, 93, 3942-3946.
57. Coussens, L. M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420, 860-867.
58. Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002). Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science, 295, 2387-2392.